Physician profile
Charles T Wright
NPI 1013064831
$3,056.42
in general payments reported to CMS, 2019-2025
23 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $91.77 · 2021: $232 · 2022: $592 · 2023: $566 · 2024: $564 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,725.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $739.59 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $574.61 | 2021-2025 | Dupixent, Libtayo |
| Stryker Corporation | $552.08 | 2019-2025 | Scopis Ent |
| Glaxosmithkline, LLC. | $289.01 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $178.88 | 2023 | Codman Isocool Aht, Instruments-Orthopedic, Integra Duo |
| Optinose US, INC. | $124.23 | 2020-2024 | |
| Siemens Medical Solutions USA, INC. | $88.22 | 2024 | |
| Novartis Pharmaceuticals Corporation | $79.06 | 2019 | |
| Intersect Ent, INC. | $72.92 | 2019-2020 | |
| Olympus America INC. | $55.14 | 2019 | |
| Alk-Abello, INC | $35.64 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $31.46 | 2025 | Keytruda |
| Smith+Nephew, INC. | $29.71 | 2023 | Halo |
| Endogastric Solutions, INC | $29.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.68 | 2025 | Elaprase |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $24.31 | 2022 | |
| Hologic Sales and Service, LLC | $22.35 | 2025 | Coolseal Generator |
| Inspire Medical Systems, INC. | $21.20 | 2025 | Inspire |
| Phadia US INC. | $20.63 | 2020 | |
| Medtronic, INC. | $19.37 | 2023 | Ligasure |
| Hikma Pharmaceuticals USA | $14.93 | 2025 | Ryaltris |
| Genentech USA, INC. | $14.57 | 2021 | |
| Kci USA, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.